第一单位：
Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany. johannes.breyer@ukr.de.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany. johannes.breyer@ukr.de.
作者：
Johannes,Breyer [1]
;
Markus,Eckstein [2]
;
Danijel,Sikic [3]
;
Felix,Wezel [4]
;
Florian,Roghmann [5]
;
Mirco,Brehmer [6]
;
Ralph M,Wirtz [7]
;
Jonas,Jarczyk [8]
;
Philipp,Erben [8]
;
Veronika,Bahlinger [2]
;
Franziska,Goldschmidt [9]
;
Guido,Fechner [9]
;
Jack,Chen [10]
;
Ellen,Paxinos [11]
;
Michael,Bates [11]
;
Maximilian,Haas [12]
;
Friedemann,Zengerling [4]
;
Christian,Bolenz [4]
;
Maximilian,Burger [12]
;
Arndt,Hartmann [2]
;
Maximilian C,Kriegmair [8]
;
BRIDGE Consortium e.V.
作者单位：
Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany. johannes.breyer@ukr.de.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany. johannes.breyer@ukr.de.
[1]
Institute of Pathology, Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[2]
Department of Urology and Pediatric Urology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[3]
Department of Urology and Pediatric Urology, University Hospital Ulm, Ulm, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[4]
Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[5]
Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany.
[6]
Stratifyer Molecular Pathology GmbH, Cologne, Germany.;Institute of Pathology, St. Elisabeth Hospital Köln-Hohenlind, Cologne, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[7]
Department of Urology and Urosurgery, University Hospital Mannheim Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[8]
Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[9]
Biostatistics, Cepheid Inc., Sunnyvale, CA, USA.
[10]
Medical and Scientific Affairs, Cepheid Inc., Sunnyvale, CA, USA.
[11]
Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.;BRIDGE (Bladder Cancer Research Initiative for Drug Targets Germany) Consortium E.V., Mannheim, Germany.
[12]
DOI
10.1038/s41598-023-42088-z
PMID
37723173
发布时间
2023-11-23
换一批
换一批
